Postdoctoral Positions in Translational Leukemia Research
Postdoctoral Positions in Translational Leukemia Research
The Translational Leukemia Research Program at the Perlmutter Cancer Center and New York...
Postdoctoral Positions in Translational Leukemia Research
The Translational Leukemia Research Program at the Perlmutter Cancer Center and New York University (NYU) School of Medicine invites post-doctoral applications in the laboratory of Dr. Raoul Tibes, the Director of Leukemia Program. The focus of the Laboratory is the molecular-genomic characterization of primary acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPNs) in correlation of their response to current therapies and novel investigational agents, and understanding the mechanisms of drug resistance. The Tibes laboratory has been instrumental in providing pre-clinical data based on functional genomic information for several novel treatments (i.e. epigenetic and apoptosis targeting combinations) that are currently in clinical trials for AML, MDS and MPNs. The Tibes laboratory is highly collaborative and the successful candidate will work with leading academic clinicians and basic scientists at NYU, other academic Cancer Centers, and pharmaceutical companies to discover and delineate the clinical path for novel therapeutic agents. The laboratory publishes in high-impact journals and former members of the laboratory hold positions at academic institutions or biotech and pharmaceutical companies.
Currently available projects include: understanding the mechanisms of the anti-leukemic activity DNA damage repair interference by WEE1 and CHEK1 inhibition; characterizing epigenetic/hypomethylating agent resistance and the design of rational hypomethylating agent based combinations in AML and MDS; as well as novel therapeutic approaches for MPNs.
The successful candidate will have strong dedication and independence, effectively communicate their work by publishing the results in premier journals and will be involved in grant writing with an opportunity to submit their own career awards. The applicant and projects will benefit from a scientifically stimulating environment, with extensive resources and opportunities to collaborate within NYU and externally. There is close interaction with the PI and candidates will be actively involved in various aspects of translational cancer research and drug development. The Lab is funded by several agencies including the NCI, LLS and ASCO and at the institutional level.
In addition to world-class research facilities and to opportunities within the Lab and Cancer Center, NYU Langone Health and NYU School of Medicine has a robust career development program led by our Office of Postdoctoral Affairs. One of only 17 schools to receive an NIH BEST (Broadening Experiences in Scientific Training), the Office of Postdoctoral Affairs offers over 30 courses and workshops on career planning, communication skills, negotiating, and conflict management, as well as career-specific training for careers in academia, pharma/biotech, science policy, medical communications, and many more. Additional information can be found at www.med.nyu.edu/postdoc
Requirements: Applicants should have a Ph.D. degree (or equivalent) in molecular biology, cancer biology, or relevant fields. Applicant must be able to work independently in a fast-paced, dynamic research environment.
Application process: Interested applicants should send a letter of motivation, a curriculum vitae, and the contact information of 3 references as a single combined pdf file (subject line post-doctoral application) to [email protected].
Below are some other jobs we think you might be interested in.
-
Postdoctoral Research Associate - Surgery
- St. Jude Children's Research Hospital
- Memphis, TN, USA
Jun 15 -
Postdoctoral Research Associate - Oncology
- St. Jude Children's Research Hospital
- Memphis, TN, USA
Jun 15 -
Postdoctoral Research Associate - Immunology
- St. Jude Children's Research Hospital
- Memphis, TN, USA
Jun 15 -
Postdoctoral Research Associate - Developmental Neurobiology
- St. Jude Children's Research Hospital
- Memphis, TN, USA
Jun 15 -
Postdoctoral Associate Position in Tumor Immunology/Immunotherapy
- Lineberger Comprehensive Cancer Center, University of North Carolina
- Chapel Hill, NC, USA
Jun 30 -
Postdoctoral Fellowship in Immunotherapy
- Center for Cancer Research
- Bethesda, MD, USA
Jul 13 -
Postdoctoral Research Associate - Epidemiology & Cancer Control
- St. Jude Children's Research Hospital
- Memphis, TN, USA
Jun 15 -
Postdoctoral Research Scholar – Fundamental Tumor Immunology & Radiation Oncology
- Washington University School of Medicine
- Saint Louis, MO, USA
Jul 24 -
Postdoctoral Fellow in Cancer Biology and Immunology
- University of Michigan
- Ann Arbor, MI, USA
Jul 24 -
Open Rank Faculty Position in Cancer Immunotherapy
- Fred Hutch Cancer Center
- Seattle , WA
Jul 17 -
Post-Doctoral Research Fellow, Integrative Medicine & Wellness Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
- Memorial Sloan Kettering Cancer Center
- New York, NY, USA
Jun 24 -
Postdoctoral Fellow, Cancer Prevention Fellowship Program, National Cancer Institute
- National Cancer Institute
- Rockville, MD, USA
Jun 01 -
Pediatric Oncology Researcher
- University of Kentucky Healthcare, Department of Pediatrics
- Lexington, KY, USA
Jul 10 -
CANADA RESEARCH CHAIR TIER 2
- University of Manitoba
- Winnipeg, MB, Canada
Jul 15 -
Computer Science Research Assistant Professor
- Oklahoma Center of ImmunoEngineering
- Norman, OK, USA
Jul 09 -
Academic Research Scientist/Assistant/Associate/Full Professor
- University of California Davis Health System
- Sacramento, CA, USA
Jul 30 -
Chief Mission Officer
- Melanoma Research Alliance
- New York, NY, USA
- Hybrid
Jun 12 -
Professor and Program Chair, Cancer Biology
- Oklahoma Medical Research Foundation
- Oklahoma City, OK, USA
Jun 24 -
Scientific Grant Writer
- University of Miami, Sylvester Comprehensive Cancer Center
- Miami, FL, USA
- Hybrid
Jul 20 -
Stadtman Tenure-Track Investigator
- National Institutes of Health
- Bethesda, MD, USA
Jul 27


